trihexyphenidyl has been researched along with Aqueductal Stenosis in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of akinetic mutism was reported with reference to a marked improvement by levodopa, bromocriptine and trihexyphenidyl." | 1.27 | [Akinetic mutism from recurrent hydrocephalus: successful treatment with levodopa, bromocriptine and trihexyphenidyl]. ( Kurahashi, K; Matsunaga, M; Narita, S; Tanaka, T; Watahiki, Y, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watahiki, Y | 1 |
| Narita, S | 1 |
| Kurahashi, K | 1 |
| Tanaka, T | 1 |
| Matsunaga, M | 1 |
1 other study available for trihexyphenidyl and Aqueductal Stenosis
| Article | Year |
|---|---|
[Akinetic mutism from recurrent hydrocephalus: successful treatment with levodopa, bromocriptine and trihexyphenidyl].
Topics: Adult; Akinetic Mutism; Bromocriptine; Drug Therapy, Combination; Humans; Hydrocephalus; Levodopa; M | 1987 |